HC Wainwright restated their buy rating on shares of Emergent BioSolutions (NYSE:EBS – Free Report) in a report published on Friday,Benzinga reports. They currently have a $15.00 target price on the ...
Emergent BioSolutions (NYSE:EBS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback